Cargando…
Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: Th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547740/ https://www.ncbi.nlm.nih.gov/pubmed/33102388 http://dx.doi.org/10.4103/jrpp.JRPP_20_38 |
_version_ | 1783592482918891520 |
---|---|
author | Shahraki, Tahereh Gholipur Yari, Fatemeh Seirafian, Shiva Badri, Shirinsadat |
author_facet | Shahraki, Tahereh Gholipur Yari, Fatemeh Seirafian, Shiva Badri, Shirinsadat |
author_sort | Shahraki, Tahereh Gholipur |
collection | PubMed |
description | OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: This cross-sectional prospective study was carried out in the nephrology department on 117 patients who received at least two medicines. Drug interactions were determined, and the patients were evaluated for the presence of a drug complication. FINDINGS: A total of fifty ADRs were observed in 39 patients, whereas 26% of total ADRs (13 drug complications) were due to drug interactions. About 69% and 31% of complications were classified in terms of severity, in the category of “severe” and “moderate” complications, respectively. Warfarin had the highest contribution to major interactions (33.33%). CONCLUSION: ADRs, which specially occurred due to drug interactions, are particularly important for patients taking multiple medications (e.g., patient with renal insufficiency). Therefore, special attention should be paid to preventing and reducing ADRs in these patients' population. |
format | Online Article Text |
id | pubmed-7547740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-75477402020-10-22 Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases Shahraki, Tahereh Gholipur Yari, Fatemeh Seirafian, Shiva Badri, Shirinsadat J Res Pharm Pract Brief Communication OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: This cross-sectional prospective study was carried out in the nephrology department on 117 patients who received at least two medicines. Drug interactions were determined, and the patients were evaluated for the presence of a drug complication. FINDINGS: A total of fifty ADRs were observed in 39 patients, whereas 26% of total ADRs (13 drug complications) were due to drug interactions. About 69% and 31% of complications were classified in terms of severity, in the category of “severe” and “moderate” complications, respectively. Warfarin had the highest contribution to major interactions (33.33%). CONCLUSION: ADRs, which specially occurred due to drug interactions, are particularly important for patients taking multiple medications (e.g., patient with renal insufficiency). Therefore, special attention should be paid to preventing and reducing ADRs in these patients' population. Wolters Kluwer - Medknow 2020-06-26 /pmc/articles/PMC7547740/ /pubmed/33102388 http://dx.doi.org/10.4103/jrpp.JRPP_20_38 Text en Copyright: © 2020 Journal of Research in Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Brief Communication Shahraki, Tahereh Gholipur Yari, Fatemeh Seirafian, Shiva Badri, Shirinsadat Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title | Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title_full | Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title_fullStr | Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title_full_unstemmed | Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title_short | Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases |
title_sort | potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547740/ https://www.ncbi.nlm.nih.gov/pubmed/33102388 http://dx.doi.org/10.4103/jrpp.JRPP_20_38 |
work_keys_str_mv | AT shahrakitaherehgholipur potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases AT yarifatemeh potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases AT seirafianshiva potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases AT badrishirinsadat potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases |